Trial intelligence / Profile preview

Pamidronate for bone pain in cancer patients with bone metastases

IRCT2013032212197N5Phase 2Completed

Sponsor
Tonekabon Islamic Azad University
Start
Feb 2010
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of pamidronate in bone metastases and cancer-associated hypercalcemia, sponsored by Tonekabon Islamic Azad University. Primary endpoint: Bone pain improvement. Started Feb 2010; status: completed.

02

Drugs

pamidronate
03

Conditions

bone metastasescancer-associated hypercalcemia

Beyond the preview

Go deeper on IRCT2013032212197N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013032212197N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call